Apeloa Pharmaceutical's (SHE:000739) subsidiary, Zhejiang Ante Yutai Biotechnology, entered into a cooperation agreement with Shanghai Wuxi Biologics and Shanghai Duoning Biotechnology, according to a Shenzhen bourse filing on Tuesday.
Under the deal, Wuxi Biologics will provide research, development and manufacturing services to Ante Yutai.
Duoning Biotech will also provide key consumables and supporting hardware to Ante Yutai for biologics research and development, and manufacturing.
The pharmaceutical company's shares fell 3% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments